LCCC 1025: Phase II study of everolimus, trastuzumab, and vinorelbine for HER2+ breast cancer brain metastases (BCBM).
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Carey K. Anders, Allison Mary Deal, Amanda Elyse Day Van Swearingen, Marni Siegel, David N. Hayes, Heejoon Jo, Paul Little, Elizabeth Claire Dees, Hyman B. Muss, Trevor Augustus Jolly, Timothy Zagar, J Keith Smith, Julie Gottlieb Fisher, Nikita C. Shah, Lisle Nabell, Rita Nanda, Patrick Michael Dillon, Shannon Puhalla, Vandana Gupta Abramson, Lisa A. Carey
Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Carolinas Healthcare System, Levine Cancer Institute, Orlando Health, University of Alabama at Birmingham, University of Chicago, University of Virginia, University of Pittsburgh Medical Center, Vanderbilt University Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2716808802